LenioBio develops rapid plant-based, cell-free protein expression that scales for research, development and production.
LenioBio has raised $4.4M in total funding. The most recent round was Grant. The last funding was announced in July 2025.
LenioBio's investors include EIT Food, Eurostars, Bridford Group, European Health and Digital Executive Agency.
LenioBio is headquartered in Düsseldorf, Germany.
LenioBio develops rapid plant-based, cell-free protein expression that scales for research, development and production.
LenioBio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LenioBio — Funding & Investors." VCBacked, July 1, 2025, https://www.vcbacked.co/company/leniobio. Accessed September 30, 2026.
VCBacked. (2025). LenioBio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/leniobio
{{cite web |title=LenioBio — Funding & Investors |url=https://www.vcbacked.co/company/leniobio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated